STOCK TITAN

BlackRock ESG Capital Allocation Term Trust (ECAT) Form 4 Filings

ECAT NYSE

Here are the Form 4 insider transactions from BlackRock ESG Capital Allocation Term Trust (ECAT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ECAT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ECAT filings page.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On February 2, 2026, it sold 178,239 common shares at $15.55 per share in an open-market transaction coded as a sale.

After this transaction, Saba Capital Management, L.P. beneficially owned 24,968,217 ECAT common shares, held indirectly. The filing reflects an adjustment to an existing large position rather than an initial purchase or complete exit.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported selling common stock in two January transactions.

It sold 166,027 shares at $15.44 on January 29 and 157,827 shares at $15.46 on January 30. After these indirect sales, it still beneficially owned 25,146,456 common shares.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two transactions. On January 27, 2026, it sold 83,984 shares at $15.54 per share. On January 28, 2026, it sold a further 105,896 shares at $15.53 per share. After these sales, Saba Capital Management, L.P. reported 25,470,310 ECAT shares beneficially owned indirectly.

Rhea-AI Summary

Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a routine share sale. On January 26, 2026, the firm sold 44,054 shares of ECAT common stock at a price of $15.54 per share, coded as a sale transaction.

After this trade, Saba Capital Management, L.P. reported indirect beneficial ownership of 25,660,190 ECAT common shares. The filing lists the ownership form as indirect, without specifying a particular intermediary entity in the ownership description.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On January 22, 2026, Saba sold 35,831 ECAT shares at $15.50 per share. On January 23, 2026, it sold an additional 58,213 shares at $15.50 per share. After these transactions, Saba reported indirect beneficial ownership of 25,704,244 ECAT common shares.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares of the fund in two January transactions. On January 20, 2026, it sold 102,837 common shares at $15.39 per share, leaving 25,968,064 shares beneficially owned on an indirect basis. On January 21, 2026, it sold a further 169,776 common shares at $15.38 per share, after which it beneficially owned 25,798,288 common shares, also reported as indirect ownership.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On January 15, 2026, it sold 80,452 shares at $15.97 per share. On January 16, 2026, it sold another 75,435 shares at $15.94 per share.

After these transactions, Saba Capital Management, L.P. reported beneficial ownership of 26,146,336 ECAT shares following the first sale and 26,070,901 shares following the second sale, all held indirectly.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two January 2026 transactions. On January 13, 2026, it sold 11,153 shares at a price of $15.92 per share, leaving 26,302,501 shares beneficially owned indirectly after that trade. On January 14, 2026, it sold a further 75,713 shares at $15.89 per share, bringing its indirect beneficial ownership to 26,226,788 ECAT shares following the second transaction.

Rhea-AI Summary

Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On January 6, 2026, Saba Capital sold 9,943 ECAT common shares at a price of $15.75 per share. After this transaction, Saba Capital beneficially owned 26,313,654 ECAT common shares, reported as held indirectly.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a small stock sale. On 01/02/2026, the firm sold 12,660 shares of ECAT common stock in an open-market transaction coded "S" at a price of $15.45 per share. After this transaction, Saba Capital reported beneficial ownership of 26,323,597 shares, held indirectly.

Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust insider activity shows a small share sale by a large holder. On 12/24/2025, a reporting person associated with the trust sold 1,100 shares of common stock at a price of $15.57 per share, identified with transaction code "S" for a sale. After this transaction, the reporting person beneficially owned 26,336,257 shares, reported as indirect ownership.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported several recent transactions in the trust’s common shares. On November 28, 2025, Saba sold 9,389 indirect shares at $16.02 each. On the same date, 334,659 indirect shares were reduced at a price of $0, described as a pro-rata distribution in-kind for no consideration. After these moves, its indirectly owned position was 26,391,751 shares. On December 1, 2025, Saba sold an additional 54,394 indirect shares at $16.03, leaving it with 26,337,357 ECAT shares held indirectly.

Rhea-AI Summary

Saba Capital Management, L.P., a director and 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/26/2025, the reporting person sold 56,976 shares of ECAT common stock at a price of $16 per share, marked with transaction code "S" for a sale. Following this transaction, the reporting person reported 26,735,799 shares of ECAT common stock beneficially owned with indirect ownership.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of the trust’s common stock. On 11/25/2025, the firm sold 49,669 ECAT common shares at a price of $15.8 per share, using transaction code "S" for a sale. After this transaction, Saba Capital Management, L.P. reported beneficial ownership of 26,792,775 ECAT common shares, held indirectly.

Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner. On 11/24/2025, the reporting person executed a sale of 10,891 shares of common stock at a price of $15.65 per share, coded as an "S" transaction. After this sale, the reporting person reported 26,842,444 shares beneficially owned in an indirect capacity. The filing was made on Form 4 by a single reporting person and reflects a routine update to their equity holdings.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/19/2025, Saba disposed of 9,750 shares of ECAT common stock in an open-market sale at a price of $15.64 per share. After this transaction, Saba reported beneficial ownership of 26,853,335 ECAT shares, held indirectly. This filing is a routine disclosure of insider trading activity required for large shareholders.

Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner on a Form 4. On 11/17/2025, the reporting person executed a sale of 44,604 shares of common stock at a price of $15.85 per share. After this transaction, the reporting person reported 26,863,085 shares of ECAT common stock beneficially owned in an indirect capacity. The filing reflects a routine update to the insider’s reported holdings and confirms the relationship as a 10% owner of the trust.

Rhea-AI Summary

Saba Capital Management, L.P., a reporting person associated with BlackRock ESG Capital Allocation Term Trust (ECAT), reported open-market sales of the trust’s common stock on a Form 4. On 11/13/2025, it sold 62,082 shares at $16.45 per share, and on 11/14/2025 it sold 90,456 shares at $16.30 per share. After these transactions, the reporting person indirectly beneficially owned 26,907,689 common shares of ECAT.

Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust (ECAT): A Form 4 shows a 10% owner reported open-market sales. Saba Capital Management, L.P. executed two sales of ECAT common stock: 17,653 shares at $16.28 on 11/10/2025 and 39,740 shares at $16.39 on 11/11/2025. Following these transactions, the reporting person beneficially owns 27,060,227 shares, held indirectly.

Rhea-AI Summary

Saba Capital Management, L.P. filed a Form 4 for BlackRock ESG Capital Allocation Term Trust (ECAT), reporting an open-market sale of 57,053 common shares at $16.10 per share on 11/06/2025.

After this transaction, the filer reported 27,117,620 shares beneficially owned on an indirect basis. The filing was made by one reporting person.